Suppr超能文献

肢端肥大症的手术治疗:适应证和目标。

Surgery for acromegaly: Indications and goals.

机构信息

Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.

Department of Neurosurgery, Mayo Clinic, Rochester, MN, United States.

出版信息

Front Endocrinol (Lausanne). 2022 Aug 4;13:924589. doi: 10.3389/fendo.2022.924589. eCollection 2022.

Abstract

Acromegaly is a disease that occurs secondary to high levels of GH, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects. Diagnosis includes serum GH and IGF-1 levels, and obtaining an MRI pituitary protocol to assess for a functional pituitary adenoma. Attempted gross total resection of the GH-secreting adenoma is the gold standard in treatment for patients with acromegaly for a goal of biochemical remission. Medical and radiation therapies are available when patients do not achieve biochemical cure after surgical therapy.

摘要

肢端肥大症是一种由 GH 水平升高引起的疾病,最常见于由分泌激素的垂体腺瘤引起,伴有多系统不良影响。诊断包括血清 GH 和 IGF-1 水平,并进行垂体 MRI 方案以评估功能性垂体腺瘤。对于肢端肥大症患者,试图进行 GH 分泌腺瘤的大体全切除是治疗的金标准,目的是实现生化缓解。当患者在手术治疗后未达到生化治愈时,可采用药物和放射治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ab3/9386525/e071a6affee1/fendo-13-924589-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验